Literature DB >> 16331428

Different labelling of obstructive airway diseases in Estonia, Finland, and Sweden.

Paula Pallasaho1, Mari Meren, Aet Raukas-Kivioja, Eva Rönmark.   

Abstract

Large differences in prevalence of asthma have been reported between westernised countries and the former Eastern European countries, and still no consensus about the reasons for the differences exists. The aim of this study was to assess diagnostic labelling of obstructive airway diseases, comparing subjects with respiratory symptoms and the diagnoses obtained in Estonia, Finland, and Sweden. A postal questionnaire was sent to population-based random samples, and 44,483 (76%) answers were obtained from the 58,661 invited in 1996. Among men, current smoking was most common in Estonia, 60%, followed by Finland, 39%, and Sweden, 28%. In all three countries, 30% of women were current smokers. Most respiratory symptoms including wheezing were most common in Estonia, also among non-smokers. The prevalence of asthma was 2.0% and chronic bronchitis 10.7% in Estonia, while the opposite was found in Sweden with an asthma prevalence of 7.8% and a chronic bronchitis prevalence of 3.1%. The pattern in Finland was similar to that of Sweden. The same differences between the three countries were found also among young subjects. The total proportion of diagnosed obstructive lung diseases in subjects with respiratory symptoms was similar, but the diagnosis of asthma was considerably more common in Finland and Sweden. Chronic bronchitis was favoured in Estonia, also among young adults irrespectively of what symptoms were present. In a multivariate model with correction for confounders, the risk (OR) for having a diagnosis of asthma was 5.65 (95% CI: 4.86-6.56) when living in Sweden, and 3.51 (95% CI: 3.00-4.12) in Finland, whereas risk for chronic bronchitis was 0.28 (0.25-0.31) and 0.22 (0.19-0.25), respectively, compared to Estonia. The study indicates differences in diagnostic practices of obstructive lung diseases between the three countries.

Entities:  

Mesh:

Year:  2005        PMID: 16331428     DOI: 10.1007/s10654-005-4117-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

Review 1.  Defining asthma in epidemiological studies.

Authors:  J Pekkanen; N Pearce
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

Review 2.  COPD: the scope of the problem in Europe.

Authors:  R Pauwels
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

3.  Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease.

Authors:  M D Lebowitz; R J Knudson; B Burrows
Journal:  Am J Epidemiol       Date:  1975-08       Impact factor: 4.897

4.  Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn.

Authors:  P Pallasaho; B Lundbäck; M Meren; J Kiviloog; H M Loit; K Larsson; L A Laitinen
Journal:  Respir Med       Date:  2002-10       Impact factor: 3.415

5.  Low socio-economic status is a risk factor for respiratory symptoms: a comparison between Finland, Sweden and Estonia.

Authors:  P Pallasaho; M Lindström; J Põlluste; Helle-Mai Loit; A Sovijärvi; B Lundbäck
Journal:  Int J Tuberc Lung Dis       Date:  2004-11       Impact factor: 2.373

6.  Prevalence of asthma in Finnish young men.

Authors:  T Haahtela; H Lindholm; F Björkstén; K Koskenvuo; L A Laitinen
Journal:  BMJ       Date:  1990-08-04

7.  Hay fever, hygiene, and household size.

Authors:  D P Strachan
Journal:  BMJ       Date:  1989-11-18

8.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Authors:  B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

9.  Asthma, chronic bronchitis and respiratory symptoms among adults in Estonia according to a postal questionnaire.

Authors:  M Meren; L Jannus-Pruljan; H M Loit; J Põlluste; E Jönsson; J Kiviloog; B Lundbäck
Journal:  Respir Med       Date:  2001-12       Impact factor: 3.415

10.  Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey.

Authors:  B Lundbäck; L Nyström; L Rosenhall; N Stjernberg
Journal:  Eur Respir J       Date:  1991-03       Impact factor: 16.671

View more
  4 in total

1.  Respiratory symptoms increase health care consumption and affect everyday life - a cross-sectional population-based study from Finland, Estonia, and Sweden.

Authors:  Malin Axelsson; Anne Lindberg; Annette Kainu; Eva Rönmark; Sven-Arne Jansson
Journal:  Eur Clin Respir J       Date:  2016-05-27

2.  Chronic traffic-induced PM exposure and self-reported respiratory and cardiovascular health in the RHINE Tartu Cohort.

Authors:  Hans Orru; Rain Jõgi; Marko Kaasik; Bertil Forsberg
Journal:  Int J Environ Res Public Health       Date:  2009-10-30       Impact factor: 3.390

3.  Exposure to animals and the risk of allergic asthma: a population-based cross-sectional study in Finnish and Russian children.

Authors:  Timo T Hugg; Maritta S Jaakkola; Risto Ruotsalainen; Vadim Pushkarev; Jouni J K Jaakkola
Journal:  Environ Health       Date:  2008-06-06       Impact factor: 5.984

4.  High prevalence of rhinitis symptoms without allergic sensitization in Estonia and Finland.

Authors:  Paula Pallasaho; Annette Kainu; Maria Juusela; Mari Meren; Anssi Sovijärvi
Journal:  Eur Clin Respir J       Date:  2015-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.